Prophylactic rituximab administration in children with complicated nephrotic syndrome.

Mika OkutsuKoichi KameiMai SatoToru KanamoriKentaro NishiSho IshiwaMasao OguraMayumi SakoShuichi ItoKenji Ishikura

Published in: Pediatric nephrology (Berlin, Germany) (2020)

Additional rituximab treatment at B cell recovery can maintain prolonged remission even after B cell recovery in patients with complicated nephrotic syndrome with history of SRNS.

Keyphrases

diffuse large b cell lymphoma
hodgkin lymphoma
chronic lymphocytic leukemia
young adults
rheumatoid arthritis
systemic lupus erythematosus
combination therapy